In particular, the Nodal/Activin signalling-pathway components were found to be overexpressed in pancreatic cancer stem cells and to potentially increase the plasticity of tumour cells through ALK4/7 receptors33. The gene discussed is NODAL; the disease is pancreatic neoplasm.